Point-of-care Low-field MRI in Acute Stroke

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

November 1, 2026

Conditions
StrokeIschemic StrokeHemorrhagic StrokeMagnetic Resonance Imaging
Interventions
DEVICE

Portable low-field MRI

"Three FDA-approved low-field (LF) portable MRI commercialized by Hyperfine Research Inc. (www.hyperfine.io) will be employed. Patients will undergo LF-MRI in the CT suite during the downtime of preparation which usually occurs after urgent imaging in the CT suite (mean time, as calculated basing on the current door to imaging time: \~20-25 minutes), thus not delaying the conventional diagnostic processes and treatment administration. LF-MRI will be also repeated by the study staff at predefined time-points: 24 h, 72 h, at the discharge and 4 weeks after the event.~A prespecified acquisition of Fast-Spin Echo (Fast-SE) essential stroke sequences will be performed, starting with diffusion weighted imaging (DWI) + apparent diffusion coefficient (ADC) mapping and fluid attenuated inversion recovery (FLAIR)."

Trial Locations (4)

20089

IRCCS Humanitas Research Hospital of Rozzano, Milan

66100

SS Annunziata Hospital of Chieti, Chieti

67051

SS Filippo e Nicola Hospital of Avezzano, Avezzano

67100

S Salvatore Hospital of L'Aquila, L’Aquila

All Listed Sponsors
lead

University of L'Aquila

OTHER

NCT05816213 - Point-of-care Low-field MRI in Acute Stroke | Biotech Hunter | Biotech Hunter